Interaction of Apelin and Angiotensin in the Human Forearm Circulation
Heart Disease, Vasodilation

About this trial
This is an interventional basic science trial for Heart Disease focused on measuring Renin angiotensin system, Apelin, Vasodilatation, Heart disease, Vascular biology
Eligibility Criteria
Inclusion Criteria:
- > 18 years old
- Healthy volunteers
Exclusion Criteria:
- Lack of informed consent
- Age < 18 years,
- Current involvement in other research studies,
- Systolic blood pressure >190 mmHg or <100 mmHg
- Malignant arrhythmias
- Renal or hepatic failure
- Haemodynamically significant aortic stenosis
- Severe or significant co morbidity
- Women of childbearing potential.
Any regular medication
- Previous history of any cardiovascular disease
Sites / Locations
- Clincial Research Facility, Royal Infirmary of Edinburgh, 51 Little France Cresc
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Infusion of apelin
Sodium nitroprusside infusion
Using forearm venous occlusion plethysmography apelin will be infused to cause reduction in forearm blood flow. Infusion of angiotensin II and noradrenaline will given and vasoconstriction will be assessed. Blood samples for the infused arm and contra-lateral arm will be taken at regular time points to assess local and systemic changes in relevant hormones.
Using forearm venous occlusion plethysmography sodium nitroprusside will be infused to cause reduction in forearm blood flow. Infusion of angiotensin II and noradrenaline will given and vasoconstriction will be assessed. Blood samples for the infused arm and contra-lateral arm will be taken at regular time points to assess local and systemic changes in relevant hormones.